Medical editor

A 29-year-old physician from Bristol has had her eyesight stored after a “game-changing” take a look at recognized a thriller an infection that had plagued her well being for 5 years.
Ellie Irwin suffered continual irritation in her proper eye leading to blurred imaginative and prescient and underwent in depth remedy to no avail. At one level she even regarded as having her eye got rid of.
It used to be best after Ellie used to be introduced a “last resort” research known as metagenomics, that she used to be recognized with a unprecedented bacterial an infection which used to be cured with antibiotics.
“It’s been transformative,” Ellie advised the BBC. “I feel so fortunate.”
Professor Carlos Pavesio, advisor ophthalmologist at Moorfields Eye Hospital in London, says Ellie’s case is a “breakthrough in the diagnosis of infectious diseases”.
“There are many patients we treat with chronic infections for years, but despite multiple tests we cannot identify the bug responsible,” he says.
In 2019, whilst nonetheless at scientific college, Ellie started affected by irritation in her proper eye. All checks for an infection got here again destructive and it used to be assumed she had an autoimmune situation.
Ellie used to be prescribed steroid eye drops and immunosuppressants, a few of which had to be given by way of intravenous infusion.
“It was completely dominating my life,” Ellie says. “I needed eye drops every single hour and it was difficult to balance that alongside starting work as a junior doctor. My vision was really variable, and I would have some bad days.
“I used to be on such a lot drugs and going to such a lot of appointments, but I did not really feel I used to be getting any higher.”
The treatment and inflammation led to Ellie developing a cataract that had to be surgically removed, just after she graduated from medical school.
Ellie says she eventually reached “verge of collapse”, and even began considering having her affected eye removed.
“Whilst shedding sight in a single eye is terrifying,” she says, “my largest worry used to be that it could unfold to my left eye.”

It was one of Ellie’s doctors at Southmead Hospital in Bristol who suggested metagenomics – a last resort test not generally available to patients and only used where standard diagnostic tools have failed to identify or rule out infection.
Metagenomics technology uses cutting-edge genomic sequencing, which can identify all bacteria, funghi or parasites present in a sample by comparing them against a database of millions of pathogens.
A team at Moorfields Eye Hospital arranged for a sample of fluid to be taken from inside Ellie’s eye and sent to the metagenomics labs at Great Ormond Street Hospital (GOSH) – the only lab in the UK officially recognised to carry out these diagnostic tests for patients, and one of only a few in the world.
Currently, the standard method for detecting bacterial infections is by trying to grow a sample of it in a Petri dish.
For viruses, the most common diagnostic tool is a PCR test. These will be familiar to many from the pandemic, when millions sent off swabs in the post to confirm whether they had Covid.
However, Dr Julianne Brown, principal clinical scientist at the GOSH metagenomics service, says PCR has some drawbacks.
“The hassle with PCR is that you need to call to mind the viruses that could be inflicting an an infection and do a separate take a look at for each one,” she says. “So if you have got an an infection with one thing that is surprising, uncommon or now not in the past identified, you will not in finding it.”
Dr Brown says metagenomics is “a huge step up – it is a whole game-changer”.

In Ellie’s case, metagenomics diagnosed a rare strain of the bacterial infection leptospirosis found in South America.
It is now presumed Ellie picked up the bug swimming in the Amazon river in 2018, while on a trip to Ecuador and Colombia.
Ellie says it was an emotional moment when she was given the results of the test.
“I broke down – I simply needed to cry. I by no means imagined that it will come again certain and be for one thing that used to be treatable,” she says.
“I used to be given 3 weeks of antibiotics and inside days my imaginative and prescient used to be clearer and the irritation subsided.”
A single metagenomics test costs around £1,300, which is far more than standard diagnostics. However, as the technology is developed that price is likely to fall rapidly.
Virologist Professor Judy Breuer, who has been developing metagenomics at GOSH and University College London (UCL) for more than a decade, says her team currently receives three or four samples a week from hospitals around the UK for metagenomic testing in addition to those it carries out on its own patients.
These are often samples from parts of the body that are normally sterile sites, where bacteria are not usually found such as the brain, central nervous system, liver and eye.
“In the long run, we expect metagenomics will change into a primary line take a look at and be capable of diagnose an infection in any pattern, most probably inside the similar day,” she says.
It’s also likely to become faster, cheaper and easier to do, explains Dr Brown, meaning it will become available to more patients rather than just a small number who are severely unwell.

Resolving her eye problems has allowed Ellie to concentrate on her training as a GP and arrange her wedding.
Ellie was married in Newcastle on 29 March, the same day the city celebrated Newcastle United’s win in the Carabao Cup.
She says: “We were given a shout-out from Ant and Dec and went up on a scissor raise above the Newcastle United enthusiasts, which used to be improbable.”
Prof Breuer says she is thrilled with how the treatment is changing lives.
“It is fantastic to peer the affect it’s having for sufferers like Ellie.”